FLUNARIZINE, A CALCIUM-ENTRY BLOCKER, IN CHILDHOOD MIGRAINE, EPILEPSY, AND ALTERNATING HEMIPLEGIA

被引:11
作者
CAERS, LI [1 ]
DEBEUKELAAR, F [1 ]
AMERY, WK [1 ]
机构
[1] JANSSEN PHARMACEUT NV,DEPT DEV,B-2340 BEERSE,BELGIUM
关键词
D O I
10.1097/00002826-198704000-00006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:162 / 168
页数:7
相关论文
共 23 条
[1]   CLINICAL TRIAL DESIGN AVOIDING UNDUE PLACEBO TREATMENT [J].
AMERY, W ;
DONY, J .
JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 15 (10) :674-679
[2]   BRAIN HYPOXIA - THE TURNING-POINT IN THE GENESIS OF THE MIGRAINE ATTACK [J].
AMERY, WK .
CEPHALALGIA, 1982, 2 (02) :83-109
[3]   FLUNARIZINE, A CALCIUM ENTRY BLOCKER IN MIGRAINE PROPHYLAXIS [J].
AMERY, WK ;
CAERS, LI ;
AERTS, TJL .
HEADACHE, 1985, 25 (05) :249-254
[4]  
AMERY WK, 1981, DRUG EXP CLIN RES, V7, P1
[5]  
ANDERMANN F, 1986, NEUROLOGY, V36, P327
[6]  
ARAKI G, 1982, KISO RINSHO, V16, P171
[7]   OPEN DOSE-RANGING TRIAL OF FLUNARIZINE AS ADD-ON THERAPY IN EPILEPSY [J].
BINNIE, CD ;
DEBEUKELAAR, F ;
MEIJER, JWA ;
MEINARDI, H ;
OVERWEG, J ;
WAUQUIER, A ;
VANWIERINGEN, A .
EPILEPSIA, 1985, 26 (05) :424-428
[8]  
CAERS L I, 1985, Journal of Neurology, V232, P160
[9]  
CASAER P, 1984, LANCET, V2, P579
[10]  
CASAER P, 1986, G NEUROPSICOFARMA S2, V8, P19